LLY
NYSE
Healthcare
Eli Lilly and Company
n/a
price not loaded
Financials
Select any card to open it. The button on a card or stat shows where that number comes from.
Annual figures
Eli Lilly and Company (LLY) reported revenue of $23.0B, net income of $7.09B and diluted EPS of $7.94 in the quarter ended Jun 30, 2026. The table lists its latest fiscal years as originally reported in its SEC filings; the interactive charts show the same figures by quarter.
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| Fiscal 2025ended Dec 31, 2025 | $65.2B | $20.6B | $22.95 | $8.97B |
| Fiscal 2024ended Dec 31, 2024 | $45.0B | $10.6B | $11.71 | $3.76B |
| Fiscal 2023ended Dec 31, 2023 | $34.1B | $5.24B | $5.80 | $793M |
| Fiscal 2022ended Dec 31, 2022 | $28.5B | $6.24B | $6.90 | $5.23B |
As originally reported. A figure a company did not report says so; nothing is estimated or filled in.